688799 华纳药厂
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.10112.3919.31812.73011.886
总资产报酬率 ROA (%)1.9908.6447.08810.0979.605
投入资产回报率 ROIC (%)2.31910.2698.52012.04411.343

边际利润分析
销售毛利率 (%)56.52060.28561.63064.78567.712
营业利润率 (%)11.31915.98711.44916.54915.163
息税前利润/营业总收入 (%)11.75616.00110.23015.18414.494
净利润/营业总收入 (%)9.77815.1649.82113.47313.413

收益指标分析
经营活动净收益/利润总额(%)90.24359.97996.83596.90293.022
价值变动净收益/利润总额(%)4.29535.009-11.5431.5594.091
营业外收支净额/利润总额(%)-0.2700.170-0.055-3.147-0.534

偿债能力分析
流动比率 (X)2.5712.8643.4214.0134.234
速动比率 (X)1.6891.9082.4362.9343.083
资产负债率 (%)38.24333.10725.90118.77417.439
带息债务/全部投入资本 (%)24.86417.6646.2772.3762.068
股东权益/带息债务 (%)288.109443.8171,411.6123,980.9374,575.411
股东权益/负债合计 (%)161.487202.054283.082421.701455.722
利息保障倍数 (X)25.141-1,143.054-8.441-17.654-24.640

营运能力分析
应收账款周转天数 (天)54.39545.31441.33439.24738.762
存货周转天数 (天)244.432242.519257.343250.413275.918